GE Healthcare of Chalfont St. Giles, U.K., has settled one of the first lawsuits scheduled to go to trial over charges that its Omniscan MRI contrast agent caused nephrogenic systemic fibrosis (NSF).
The lawsuit was filed by Loralei Knase of Coon Rapids, MI, who was injected with Omniscan several times between 2003 and 2005, according to the online news organization ProPublica. Knase had severe kidney disease, and after the scans she developed symptoms of NSF and is now disabled, according to a ProPublica article.
In an e-mail to AuntMinnie.com, Sebastien Duchamp, GE global public relations director, acknowledged that the Knase case has been settled.
"The Knase matter has been resolved to the mutual satisfaction of both parties," Duchamp said. "The settlement is confidential, and it does not represent an admission of wrongdoing by the company. Patient safety is our No. 1 priority at GE Healthcare. The company remains committed to improving the quality and efficiency of healthcare around the world."
Related Reading
GE Healthcare profit grows 10% in Q4, January 21, 2011
GE inks angio navigation deal with Veran Medical, January 19, 2011
GE touts flutemetamol studies for AD, January 14, 2011
GE brings imaging to Fiesta Bowl title game, January 10, 2011
GE taps new European head, January 5, 2011
Copyright © 2011 AuntMinnie.com
